The current pandemic has taught us that now more than ever, stay-at-home solutions are crucial for the ongoing provision of healthcare, particularly to elderly and more vulnerable patients suffering from multiple chronic diseases.

Thus, the onus has fallen on companies in the pharmaceutical packaging/drug delivery world to address the adherence challenges that arise from this shift to the home setting. Senior patients tend to have difficulty in using devices such as injectors, patches, eye droppers and inhalers, in terms of the challenging preparatory, administration and disposal steps required.

In the third Pharmapack podcast of this series, in partnership with Lund University in Sweden, and discussing with academic and industry experts, we will explore not only how companies should approach the design of senior-friendly self-administered drug devices by putting the patient and their physical and cognitive limitations at the heart of their programmes, but also how they can keep older patients involved and engaged at every phase of the development process.